Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Alexey Danilov

Alexey Danilov

MD, PhD
City of Hope

Academic History

Alexey Danilov, MD, PhD, earned both his medical degree and PhD at the Yaroslavl State Medical Academy, Yaroslavl, Russia. He then completed his residency at Brown University, Providence, RI, and a fellowship in Hematology / Oncology at Tufts Medical Center, Boston, MA.

Prof. Danilov is an Associate Director at the Toni Stephenson Lymphoma Center. He is also a Professor in the Division of Leukemia of the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, Duarte, CA. As Translational Medicine Chair of the SWOG Lymphoma Committee, Prof. Danilov participates in drug discovery on a global scale.

Speaking on new targeted agents for lymphoid malignancies

As a physician-scientist with a background in molecular biology and oncologic drug development, Prof. Danilov focuses his research on experimental therapeutics in lymphoid malignancies, including chronic lymphocytic leukemia (CLL). More specifically, his lab investigates drug resistance in lymphomas as well as novel targets in the ubiquitin-proteasome system. Building on his pre-clinical discoveries, he has launched multiple early-phase clinical trials with novel agents.